High level of circulating vitamin D during neoadjuvant therapy may lower risk of metastatic progression in high-risk rectal cancer

Table 2 Serum content of vitamin D and correlations with other circulating factors^a

Abbreviations: CEA carcinoembryonic antigen, CRP C-reactive protein, ESR erythrocyte sedimentation rate, LDH lactate dehydrogenase, NLR neutrophil-to-lymphocyte ratio
^aAll measures of circulating factors but 25-hydroxyvitamin D were log-transformed before analysis
^bEstimated by Pearson correlation test
^cSignificant p-value did not persist after correction for multiple comparisons of 12 datasets on circulating markers possibly related to tumor immune responses, which excluded that on CEA

ISSN: 1471-2407